Insurers requesting the confidential sales materials for StarStone will find a global specialty insurer in far ruder health than the one which Enstar acquired from its private equity backers in 2014.
However, although the business - bought by the
legacy player as a turnaround project - has reached underlying
profitability it is yet to deliver a high return on equity to its
owners.
As such the pitch is likely to rely upon a continuation of the steady improvement in underwriting,...
If you are a non-subscriber but would like to be able to view this article, then please go to our Publications page for further information on joining our readership